RxDoctor Payments Data

Tina Lopez

Family · Cherry Hill, NJNPI 1841613999

Payments from drug & device makers

$1,121in general payments, 2019–2025

Across 89 payments — averaging $12.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$346
  • Novo Nordisk$160
  • AstraZeneca$90
  • Amgen$79
  • Eisai Inc.$57
  • Abbott$45
  • plus $343 from 17 others

What the payments were for

  • Food & beverage$1,121100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,121 in reported general payments places this provider in the 75th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$50,328
OzempicSemaglutide38$50,202
JardianceEmpagliflozin27$34,311
TrulicityDulaglutide20$24,382
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$18,962
XareltoRivaroxaban15$18,094
MounjaroTirzepatide13$16,484
FarxigaDapagliflozin Propanediol13$16,263
JanuviaSitagliptin Phosphate16$15,579
LinzessLinaclotide13$14,819
MyrbetriqMirabegron14$11,186
TrulancePlecanatide11$6,195
BrilintaTicagrelor12$6,003
VascepaIcosapent Ethyl14$4,965
Atorvastatin Calcium370$4,860

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$160$50,20238 claims
Lilly USA, LLCTrulicity, Mounjaro$19$40,86633 claims
Boehringer IngelheimJardiance$42$34,31127 claims
AstraZenecaFarxiga, Brilinta, Symbicort$90$24,59536 claims
GSKTrelegy Ellipta$41$18,96222 claims
Johnson & JohnsonXarelto$13$18,09415 claims
AbbVieLinzess, Synthroid$346$17,26042 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$28$6,19511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,692 family providers in New Jersey.

Other family in Cherry Hill

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →